New HER2-testing guidelines result in more women eligible for HER2-directed treatment

New guidelines for immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH) pathology testing categorize more breast cancers as “equivocal” regarding HER2 positivity and ultimately...
Source: Ob.Gyn. News - Category: OBGYN Source Type: research